Integra LifeSciences | IART - Sales Revenues


Integra LifeSciences reported $415.6M in Sales Revenues for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 3.67B
Cash and Equivalent USD 217.91M
Cost of Sales USD 206.27M
Current Assets USD 1.14B
Current Liabilities USD 929.81M
Debt USD 2.01B
EBIT USD -509.91M
EBITDA USD -472.22M
Employees 4.4K
EPS Earnings Per Share USD 0.45
Equity Capital and Reserves USD 1.04B
Gross Profit on Sales USD 209.33M
Interest Expense on Debt USD 21.04M
Interest Income USD 4.71M
Loan Capital USD 1.23B
Market Capitalization USD 1.25B
Net Income USD -484.07M
Operating Expenses USD 416.91M
Operating Profit USD -1.31M
Ordinary Share Capital USD 77.92M
PE Price to Earnings USD 63.02
Pre-Tax Profit USD -530.95M
Sales Revenues USD 415.6M
Selling and Administration Expenses USD 179.89M
Stock USD 465.13M
Trade Creditors USD 92.84M
Trade Debtors USD 284.51M

Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
AtriCure USD 136.1M 12.5M Jun/2025
Baxter International USD 2.81B 180M Jun/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Boston Scientific USD 5.06B 400M Jun/2025
CONMED USD 342.34M 21.04M Jun/2025
Cooper Companies USD 1.06B 60.3M Jul/2025
Dexcom USD 1.16B 120M Jun/2025
Edwards Lifesciences USD 1.53B 120M Jun/2025
Globus Medical USD 745.3M 147.2M Jun/2025
Hologic USD 1.02B 10M Jun/2025
Insulet USD 649.1M 80.1M Jun/2025
Integra LifeSciences USD 415.6M 32.9M Jun/2025
Intuitive Surgical USD 2.44B 190M Jun/2025
J&J USD 23.74B 1.85B Jun/2025
Medtronic USD 8.6B 330M Jun/2025
Merit Medical Systems USD 382.5M 27.1M Jun/2025
Smith & Nephew USD 1.55B 140M Jun/2025
Stryker USD 6.02B 120M Jun/2025
Tandem Diabetes Care USD 240.68M 6.28M Jun/2025
Teleflex USD 780.88M 80.21M Jun/2025
Zimmer Biomet Holdings USD 2.08B 170M Jun/2025